HELSINKI, Dec 22 (Reuters) - The following stocks may be affected by newspaper reports and other factors on Monday:
The Danish enzyme maker said it had struck a development and commercialization collaboration deal with drugmaker Sanofi-Aventis (SASY.PA) for an antibiotic drug candidate.
The drug, named plectasin NZ2114, targets the treatment of severe infections, such as pneumonia and septicaemia, caused by bacteria like Staphylococcus and Streptococcus.
For more on the company, double click [NZYMb.CO]
** For a summary of upcoming results and forecasts, double click on [NORD/EQTY]
** For the western European company diary covering earnings, shareholder meetings, news conferences and analysts’ meetings, click on [WEU/EQUITY] or type in the code and hit the f9 button.
** Double click on <0#.INDEX.ST> for Swedish indices, <0#.INDEX.CO> for Danish indices, <0#.INDEX.HE> for Finnish indices and <0#.INDEX.OL> for Norwegian indices
** For constituent stock moves highlight the above codes in the command box and press the f3 button on your keyboard
** For Nordic top news items, double click on [TOP/NORD]
** For the latest news on Nordic stock price moves double click on [HOT-NORD-RTRS]
Additional reporting by Copenhagen, Oslo and Stockholm newsrooms Helsinki Newsroom; +358-9-6805-0244